ZA200904249B - New combination for use in the treatment of inflammatory disorders - Google Patents
New combination for use in the treatment of inflammatory disordersInfo
- Publication number
- ZA200904249B ZA200904249B ZA200904249A ZA200904249A ZA200904249B ZA 200904249 B ZA200904249 B ZA 200904249B ZA 200904249 A ZA200904249 A ZA 200904249A ZA 200904249 A ZA200904249 A ZA 200904249A ZA 200904249 B ZA200904249 B ZA 200904249B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- inflammatory disorders
- new combination
- new
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87537706P | 2006-12-18 | 2006-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200904249B true ZA200904249B (en) | 2010-08-25 |
Family
ID=37943750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200904249A ZA200904249B (en) | 2006-12-18 | 2009-06-17 | New combination for use in the treatment of inflammatory disorders |
Country Status (1)
Country | Link |
---|---|
ZA (1) | ZA200904249B (en) |
-
2009
- 2009-06-17 ZA ZA200904249A patent/ZA200904249B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200806074B (en) | Compounds for the treatment of inflammatory disorders | |
GB2463833B (en) | Compositions that prevent or reverse alpha-synuclein fibrillation for use in the treatment of neurological disorders | |
IL186749A0 (en) | Dihydrothienopyrimidines for the treatment of inflammatory diseases | |
IL197001A0 (en) | Combination treatment for metabolic disorders | |
ZA201100482B (en) | Pyrazolopyrimidines and their use for the treatment of cns disorders | |
IL195906A0 (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
IL194739A0 (en) | Dihydrothienopyrimidine for treating inflammatory disorders | |
IL195152A (en) | Compounds for use in the treatment of cell proliferative disorders | |
HK1139861A1 (en) | Pde7 inhibitors for use in the treatment of movement disorders 7(pde7) | |
HK1129426A1 (en) | Compositions for use in the enzymatic treatment of lung disorders | |
IL205578A0 (en) | Aldh-2 inhibitors in the treatment of psychiatric disorders | |
ZA200806455B (en) | Use of 2-imidazoles for the treatment of CNS disorders | |
HK1134032A1 (en) | New combination for use in the treatment of inflammatory disorders | |
GB0714447D0 (en) | Cannabidiol for use in the treatment of neurodegenerative conditions | |
IL192877A0 (en) | Use of 2-imidazoles for the treatment of cns disorders | |
IL193943A0 (en) | The use of beta- aminoalcohols for the treatment of inflammatory disorders and pain | |
IL193944A0 (en) | The use beta-aminoalcohols for the treatment of inflammatory disorders and pain | |
ZA200904249B (en) | New combination for use in the treatment of inflammatory disorders | |
HK1144247A1 (en) | Use of osteoblasts in the treatment of inflammatory rheumatic diseases | |
GB0622476D0 (en) | The treatment of inflammatory disorders and pain | |
GB0609794D0 (en) | The treatment of inflammatory disorders and pain | |
GB0722524D0 (en) | The treatment of inflammatory disorders and pain | |
GB0703494D0 (en) | The treatment of inflammatory disorders and pain | |
GB0711769D0 (en) | The treatment of inflammatory disorders and pain | |
GB0718279D0 (en) | The treatment of inflammatory disorders and pain |